Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015
Journal
Journal of clinical medicine
Journal Volume
7
Journal Issue
11
Date Issued
2018-10-27
Author(s)
Chang, Yuan-Ting
Leong, Yew-Loong
Wang, Yu-Ting
Abstract
No nationwide, long-term follow-up study has assessed medication-associated outcomes for Asian patients with inflammatory bowel disease (IBD). This study examined medication-associated outcomes for Taiwanese patients with IBD.
Subjects
5-aminosalicylic acid; anti-tumor necrosis factor-α agents; corticosteroids; inflammatory bowel disease; thiopurine
5-aminosalicylic acid; Anti-tumor necrosis factor-α agents; Corticosteroids; Inflammatory bowel disease; Thiopurine
SDGs
Other Subjects
aminosalicylic acid; corticosteroid; entecavir; ethambutol; isoniazid; lamivudine; mercaptopurine; pyrazinamide; rifampicin; tenofovir; tumor necrosis factor inhibitor; abdominal abscess; adult; Article; cohort analysis; colon resection; colorectal cancer; controlled study; drug use; environmental factor; evaluation and follow up; female; genetic susceptibility; hazard ratio; hepatitis B; hospitalization; human; hyperlipidemia; hypertension; ICD-9-CM; ileostomy; incidence; inflammatory bowel disease; laparotomy; liver cancer; long term care; major clinical study; male; medication compliance; middle aged; outcome assessment; pneumonia; recommended drug dose; retrospective study; risk factor; sepsis; Taiwanese; terminal disease; tuberculosis; urinary tract infection
Type
journal article